Disease | breast cancer |
Phenotype | C0679466|cognitive deficits |
Sentences | 7 |
PubMedID- 26026579 | Therapies for cognitive deficits associated with chemotherapy for breast cancer: a systematic review of objective outcomes. |
PubMedID- 26099816 | Chemotherapy is associated with long-term cognitive deficits in breast cancer survivors. |
PubMedID- 25678046 | Conclusions: neuroimaging analyses confirmed self-reported cognitive deficits in women with breast cancer treated with chemotherapy. |
PubMedID- 21425136 | Catechol-o-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors. |
PubMedID- 22927526 | Conclusion: results indicate that, on average, observed cognitive deficits in patients with breast cancer previously treated with chemotherapy are small in magnitude and limited to the domains of verbal ability and visuospatial ability. |
PubMedID- 25868929 | Sustained attention abnormalities in breast cancer survivors with cognitive deficits post chemotherapy: an electrophysiological study. |
PubMedID- 25621038 | However, cht-treated patients improved upon their own pre-cht baseline and performed better than patients treated without cht, indicating that the majority of long-term cognitive deficits associated with cht-treated breast cancer patients are generally small in magnitude (22). |
Page: 1